Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia.
Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Ann Thorac Surg. 2022 Sep;114(3):694-701. doi: 10.1016/j.athoracsur.2021.12.064. Epub 2022 Jan 24.
The purpose of this study was to compare the outcomes of no arch intervention, hemiarch replacement, and total arch replacement during type A aortic syndromes in a contemporary series.
From 2004 to 2019, 634 patients have required acute type A dissection repair; these patients were divided into three groups based on type of arch intervention performed: no arch (n = 130), hemiarch (n = 397), and total arch (n = 107). The primary endpoint was mortality; a multivariable risk factor analysis was performed. Secondary endpoints were reoperation and early and late complications.
Operative age was 55 ± 14 years for the cohort and was similar between groups (P = .34). The incidence of peripheral artery disease, heart failure, and prior coronary artery bypass graft surgery differed between the groups (P < .05). Median cardiopulmonary bypass time, aortic cross-clamp time, and length of stay were longest for the total arch group (P < .0001). Early mortality was 20%, 10%, and 10% for the no-arch, hemiarch, and total arch groups, respectively (P = .01). Ten-year survival was 54%, 66%, and 65% for the no-arch, hemiarch, and total arch groups, respectively (P = .01). There was no difference in incidence or timing of redo aortic interventions (P > .05). For the entire cohort, risk factors for late mortality included preoperative peripheral artery disease (hazard ratio 2.3; 95% confidence interval, 1.2 to 4.4; P = .009) and preoperative dialysis (hazard ratio 2.8; 95% confidence interval, 1.3 to 6.1; P = .01).
Despite longer cardiopulmonary bypass and aortic cross-clamp times, arch intervention was not associated with worse operative or long-term outcome in this series. Patients with peripheral vascular disease and preoperative renal failure remain at highest risk for mortality after type A aortic dissection repair.
本研究旨在比较在当代系列中,在急性 A 型主动脉综合征中不进行弓部干预、半弓置换和全弓置换的结果。
2004 年至 2019 年,634 例患者需要进行急性 A 型夹层修复;根据所进行的弓部干预类型,这些患者分为三组:不进行弓部干预(n=130)、半弓置换(n=397)和全弓置换(n=107)。主要终点是死亡率;进行了多变量危险因素分析。次要终点是再次手术和早期及晚期并发症。
该队列的手术年龄为 55±14 岁,各组之间相似(P=0.34)。外周血管疾病、心力衰竭和既往冠状动脉旁路移植术的发生率在各组之间不同(P<0.05)。全弓组的体外循环时间、主动脉阻断时间和住院时间最长(P<0.0001)。无弓组、半弓组和全弓组的早期死亡率分别为 20%、10%和 10%(P=0.01)。10 年生存率分别为无弓组 54%、半弓组 66%和全弓组 65%(P=0.01)。主动脉再次介入的发生率或时间无差异(P>0.05)。对于整个队列,晚期死亡的危险因素包括术前外周血管疾病(风险比 2.3;95%置信区间,1.2 至 4.4;P=0.009)和术前透析(风险比 2.8;95%置信区间,1.3 至 6.1;P=0.01)。
尽管体外循环和主动脉阻断时间较长,但在本研究中,弓部干预与手术或长期结果不佳无关。患有外周血管疾病和术前肾功能衰竭的患者在接受 A 型主动脉夹层修复后仍然面临最高的死亡风险。